동물용 백신 시장 규모, 점유율, 성장 분석 : 유형별, 질병별, 기술별, 투여 경로별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Veterinary Vaccines Market size was valued at USD 9.21 Billion in 2024 and is poised to grow from USD 9.86 Billion in 2025 to USD 17.08 Billion by 2033, growing at a CAGR of 7.1% during the forecast period (2026-2033).

The global veterinary vaccines market is experiencing rapid growth, largely fueled by heightened awareness of animal health and the rising demand for animal-derived products like meat, milk, and eggs. The escalating incidence of zoonotic diseases underscores the necessity for preventive measures and food security sustainability. Additionally, the expanding livestock population and a stronger emphasis on food safety bolster market demand. Innovations in vaccine development, promoting improved efficacy and safety, are becoming increasingly favored by veterinarians and pet owners alike. Significant investments from leading market players in research and development, paired with government initiatives aimed at combating animal diseases, particularly in emerging markets, are providing crucial support for market growth. The rising prevalence of animal diseases drives the adoption of vaccines, especially in poultry and ruminants.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Vaccines Market Segments Analysis

Global Veterinary Vaccines Market is segmented by Type, Disease, Technology, Route Of Administration, End User and region. Based on Type, the market is segmented into Livestock Vaccines, Porcine Vaccines, Poultry Vaccines, Companion Animal Vaccines, Aquaculture Vaccines and Other Veterinary Vaccines. Based on Disease, the market is segmented into Livestock Diseases, Porcine Diseases,Poultry Diseases, Companion Animal Diseases, Aquaculture Diseases and Other Veterinary Diseases. Based on Technology, the market is segmented into Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines and Other Vaccine Technologies. Based on Route Of Administration, the market is segmented into Subcutaneous Route of Administration, Intramuscular Route of Administration, Oral Route of Administration, Intranasal/Spray Route of Administration, Intraocular Route of Administration and Other Routes of Administration. Based on End User, the market is segmented into Veterinary Hospitals, Veterinary Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Vaccines Market

The Global Veterinary Vaccines market is significantly driven by the rising prevalence of zoonotic diseases, which are infectious illnesses that can be transmitted from animals to humans. Outbreaks of diseases such as rabies, avian influenza, and swine flu have heightened the need for effective veterinary vaccinations. By immunizing animals against these diseases, the risk of transmission to humans diminishes, which in turn helps mitigate potential disease outbreaks and enhances public health. Additionally, the growing global population and shifting dietary preferences, particularly in developing nations, have led to an increased consumption of animal protein, further intensifying the demand for veterinary vaccines.

Restraints in the Global Veterinary Vaccines Market

The global veterinary vaccines market faces significant challenges due to the intricacies and lengthy nature of vaccine development, which encompasses extensive research, clinical trials, and regulatory processes. The substantial costs associated with developing and manufacturing vaccines can render them unaffordable for many farmers and pet owners, particularly in under-resourced areas. Additionally, the expenses related to proper storage and transportation of vaccines under required conditions further elevate overall costs. These financial barriers can hinder the widespread adoption of veterinary vaccines, ultimately stifling market growth, especially in developing regions where resources are constrained.

Market Trends of the Global Veterinary Vaccines Market

A notable trend in the global veterinary vaccines market is the rising adoption of recombinant vaccines, driven by advancements in biotechnology. These innovative vaccines leverage precise targeting of pathogens, significantly enhancing efficacy and protection for both companion animals and livestock. Additionally, the hybrid nature of these vaccines minimizes adverse reactions, fostering increased trust and acceptance among veterinarians and pet owners alike. This shift towards more effective and safer vaccination options reflects a broader focus on improving animal health outcomes and aligns with growing consumer demand for high-quality veterinary care. As a result, the market is witnessing robust growth and diversification in vaccine offerings.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Supply Chain Analysis
• Trade Analysis
• Patent Analysis
• Technology Analysis
• Case Studies
• Customer And Buying Criteria Analysis

Global Veterinary Vaccines Market Size by Type & CAGR (2026-2033)

• Market Overview
• Livestock Vaccines
  • Bovine Vaccines
  • Small Ruminant Vaccines
• Porcine Vaccines
• Poultry Vaccines
• Companion Animal Vaccines
  • Canine Vaccines
  • Feline Vaccines
• Aquaculture Vaccines
• Other Veterinary Vaccines

Global Veterinary Vaccines Market Size by Disease & CAGR (2026-2033)

• Market Overview
• Livestock Diseases
  • Bovine Diseases
  • Small Ruminant Diseases
• Porcine Diseases
• Poultry Diseases
• Companion Animal Diseases
  • Canine Diseases
  • Feline Diseases
• Aquaculture Diseases
• Other Veterinary Diseases

Global Veterinary Vaccines Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Live Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Other Vaccine Technologies

Global Veterinary Vaccines Market Size by Route Of Administration & CAGR (2026-2033)

• Market Overview
• Subcutaneous Route of Administration
• Intramuscular Route of Administration
• Oral Route of Administration
• Intranasal/Spray Route of Administration
• Intraocular Route of Administration
• Other Routes of Administration

Global Veterinary Vaccines Market Size by End User & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals
• Veterinary Clinics
• Other End Users

Global Veterinary Vaccines Market Size & CAGR (2026-2033)

• North America (Type, Disease, Technology, Route Of Administration, End User)
  • US
  • Canada
• Europe (Type, Disease, Technology, Route Of Administration, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Disease, Technology, Route Of Administration, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Disease, Technology, Route Of Administration, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Disease, Technology, Route Of Administration, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hester Biosciences Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogenesis Bago (Argentina)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tianjin Ringpu Bio-Technology Co Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• China Animal Husbandry Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jinyu Bio-technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaxxinova International BV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endovac Animal Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brilliant Bio Pharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aptimmune (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Torigen Pharmaceuticals, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VEROVACCiNES GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intas Pharmaceuticals (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ourofino Animal Health (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biovac (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratoire LCV (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations